2003
DOI: 10.1128/aac.47.8.2688-2691.2003
|View full text |Cite
|
Sign up to set email alerts
|

Bovine Lactoferrin Inhibits Adenovirus Infection by Interacting with Viral Structural Polypeptides

Abstract: We recently demonstrated that lactoferrin, an antimicrobial glycoprotein, can inhibit adenovirus infection by competing for common glycosaminoglycan receptors. This study further characterizes the antiadenovirus activity of the protein, thus demonstrating that lactoferrin neutralizes infection by binding to adenovirus particles and that its targets are viral III and IIIa structural polypeptides.Lactoferrin is a multifunctional glycoprotein that possesses a variety of physiological roles, such as promotion of i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
44
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 71 publications
(45 citation statements)
references
References 35 publications
(22 reference statements)
1
44
0
Order By: Relevance
“…It is therefore likely that Lf is present at high concentration at anatomical sites where peripheral DCs encounter pathogens such as Ad5 in vivo. Lf has been demonstrated to interfere with cellular entry by viruses such as human immunodeficiency virus type 1 (Groot et al, 2005), Semliki Forest virus (Waarts et al, 2005), human papillomavirus (Drobni et al, 2004) and Ad2 Pietrantoni et al, 2003), indicating that Lf often acts to inhibit, not promote, viral entry (van der Strate et al, 2001) We found that Lf of both human and bovine origin enhanced rAd5 infection in a dose-dependent manner in all APC populations tested with the exception of PDCs. The mechanism by which this enhancement of infection occurs is probably initiated by Lf binding to rAd5, as pre-treating the cells with Lf had less effect than pre-treating the virus with Lf.…”
Section: Discussionmentioning
confidence: 67%
“…It is therefore likely that Lf is present at high concentration at anatomical sites where peripheral DCs encounter pathogens such as Ad5 in vivo. Lf has been demonstrated to interfere with cellular entry by viruses such as human immunodeficiency virus type 1 (Groot et al, 2005), Semliki Forest virus (Waarts et al, 2005), human papillomavirus (Drobni et al, 2004) and Ad2 Pietrantoni et al, 2003), indicating that Lf often acts to inhibit, not promote, viral entry (van der Strate et al, 2001) We found that Lf of both human and bovine origin enhanced rAd5 infection in a dose-dependent manner in all APC populations tested with the exception of PDCs. The mechanism by which this enhancement of infection occurs is probably initiated by Lf binding to rAd5, as pre-treating the cells with Lf had less effect than pre-treating the virus with Lf.…”
Section: Discussionmentioning
confidence: 67%
“…However, there are no data evaluating the effect of lactoferrin on the human enteric caliciviruses (sopoviruses or noroviruses). Likewise there are data showing that lactoferrin prevents adenovirus replication [17] and that the antiviral activity is located in the N terminus [18,19]. However, these studies have focused on respiratory rather than enteric adenoviral serotypes.…”
Section: Effect Of Lactoferrin On Enteric Virusesmentioning
confidence: 99%
“…Lf is produced by epithelial cells and, as a result, is present in mucosal secretions (11) such as seminal and vaginal fluids (12). One of the functions (13,14) of Lf is the transport of metals, but Lf is also an important component of the nonspecific immune system since Lf has a broad spectrum of activity against a variety of bacteria, fungi, and viruses (15). The antiviral effect of Lf lies in the early phase of infection by inhibiting attachment of viruses as alphavirus (16) to heparan sulfate glycosaminoglycans expressed on cell surface.…”
Section: S Exual Transmission Of Hiv Type 1 (Hiv-1)mentioning
confidence: 99%